GAPDH (6C5) Antibody from Santa Cruz Biotechnology, Inc.

Yes, the GAPDH (6C5) antibody has been utilized as a loading control in Western blotting, as evidenced by its citation in multiple studies, including those by Wong et al. in various contexts of cancer research (cai2022, dalton2021).

The GAPDH antibody is reactive with human, mouse, rat, and rabbit samples. It has been shown to be effective in various applications, including studies on neuroblastoma and colorectal cancer, where it was used to assess protein expression levels in relation to apoptosis and cell signaling pathways (cai2022, hristova2013).

Yes, the GAPDH antibody has been cited in studies that employed immunofluorescence to visualize protein expression in cancer cells, demonstrating its utility in this application (guo2019, park2024).

The GAPDH antibody is frequently used to normalize protein levels in studies investigating apoptosis and cell signaling pathways in various cancers, such as neuroblastoma and lung cancer. Its role as a loading control allows for accurate quantification of target proteins, thereby enhancing the understanding of cancer mechanisms and treatment responses (semba2022, islam2022).